Zdrowie i gospodarka · 01/05/2001

FDA Announces OMB Approval for Sterility Requirements for Aqueous-Based Drug Products for Oral Inhalation

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to the sterility requirements for aqueous-based drug products intended for oral inhalation, as mandated by the Paperwork Reduction Act of 1995.